The emerging role of the piRNA/piwi complex in cancer.
Liu Y, Dou M, Song X, Dong Y, Liu S, Liu H, Tao J, Li W, Yin X, Xu W. · 2019
Read The emerging role of the piRNA/piwi complex in cancer. by Liu Y, Dou M, Song X, Dong Y, Liu S, Liu H, Tao J, Li W, Yin X, Xu W. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6688334.txt.
Introduction
Liu and co-authors review the emerging role of the piRNA and PIWI complex in cancer. Their review appears in Molecular Cancer. Piwi-interacting RNAs are small non-coding molecules. They run about 24 to 31 nucleotides long. They bind PIWI proteins to regulate genes. The system was first known from the germline. It silences transposons and guards genome integrity. Expression also occurs across somatic tissues. Signalling pathways feel its influence there.
Cancer studies find abnormal piRNA expression widely. Specific piRNAs track tumour development and prognosis. Breast and lung cancers provide early examples. The review covers biogenesis in detail. Cluster transcription and ping-pong amplification feature. Biomarker and therapeutic uses close the discussion. Mechanisms remain only partly understood.
Catalog record
| CREATOR | Liu Y, Dou M, Song X, Dong Y, Liu S, Liu H, Tao J, Li W, Yin X, Xu W. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The emerging role of the piRNA/piwi complex in cancer By Yongmei Liu, Mei Dou, Xuxia Song, Yanhan Dong, Si Liu, Haoran Liu, Jiaping Tao, Wenjing Li, Xunhua Yin, Wenhua Xu Published in: Molecular Cancer DOI: 10.1186/s12943-019-1052-9 ABSTRACT Piwi interacting RNAs (piRNAs) constitute novel small non-coding RNA molecules of approximately 24–31 nucleotides in length that often bind to members of the piwi protein family to play regulatory roles. Recently, emerging evidence suggests that in addition to the mammalian germline, piRNAs are also expressed in a tissue-specific manner in a variety of human tissues and modulate key signaling pathways at the transcriptional or post-transcriptional level. In addition, a growing number of studies have shown that piRNA and PIWI proteins, which are abnormally expressed in various cancers, may serve as novel biomarkers and therapeutic targets for tumor diagnostics and treatment. However, the functions of piRNAs in cancer and their underlying mechanisms remain incompletely understood. In this review, we discuss current findings regarding piRNA biogenetic processes, functions, and emerging roles in cancer, providing new insights regarding the potential applications of piRNAs and piwi proteins in cancer diagnosis and clinical treatment. BACKGROUND PIWI-interacting RNAs (piRNAs) constitute a class of recently discovered small non-coding RNAs in germ- and somatic cells comprising 24–31 nucleotides (nt) with a 5′-terminal uridine or tenth position adenosine bias, lacking clear secondary structure motifs [1]. They were first described in 2001 in Drosophila testes as small RNAs derived from the Su(Ste) tandem repeats, which silence Stellate transcripts to maintain male fertility [2]. Unlike miRNAs and siRNAs, which typically rely on RNase type III enzymes to convert double-stranded RNA precursors into functional small RNAs, mature piRNAs derive from an initial transcript encompassing a piRNA cluster via a unique biosynthesis process [3]. piRNAs can bind to piwi proteins to form a piRNA/piwi complex, thereby influencing transposon silencing, spermiogenesis, genome rearrangement, epigenetic regulation, protein regulation, and germ stem-cell maintenance [4]. The piwi family exhibits highly conserved structure and function across multiple organisms [5], including fruit fly (PIWI, Aubergine, and AGO3 proteins) [6], mouse (MILI, MIWI, and MIWI2) [7–11], human (HILI, HIWI1, HIWI2 and HIWIL3) [6, 12–14], zebrafish (ZILI and ZIWI) [15], and nematode (PRG-1 and PRG-2) [16]. Moreover, aberrant piRNA or PIWI protein expression has recently been reported in some human cancer, with some piRNAs/piwi complexes participating in tumorigenesis and associated with cancer prognosis [17–19]. Cancer accounts for 1.2 million deaths annually in China, with an additional 1.6 million people diagnosed each year [20]. Treatments are often ineffective owing to relatively late disease detection combined with high rates of metastasis and recurrence [21], highlighting the need for novel biomarkers of cancer diagnosis and prognosis along with new targets for effective therapeutic approaches. Notably, numerous studies have implicated the piRNAs/piwi complex in the occurrence, development, metastasis, and recurrence of e.g., breast (BC) [22], lung (LC) cancer [17]. The present review summarizes the latest research regarding piRNAs including their biosynthesis, functions, and mechanism, along with their roles in different cancers and as potential biomarkers. piRNA biosynthesis mechanism Transcription of piRNA clusters A large fraction of piRNAs that can be uniquely mapped originate from two types of extended (up to 200 kb) genomic loci, termed piRNA clusters [23]. Similar to coding genes, uni-stranded clusters contain promoters marked by Pol II Ser5P and H3K4me2 peaks that produce transcripts via RNA polymerase II, which undergo5-terminal capping, 3-terminal polyadenylation, and sometimes selective splicing. Conversely, dual-strand clusters are transcribed from both genomic strands, depend on promoters of nearby coding genes to initiate transcription and are not equivalently processed [3, 23]. (Fig. 1).Fig. 1piRNA biosynthesis mechanism. Within the nucleus, two types of piRNA clusters are transcribed to produce the primary piRNAs, Zuc and its co-factors incised primary piRNAs producing piRNA intermediates with a 5′ uracil in Yb body. piRNA intermediates linked piwi that are cleavage by Zuc or Papi-dependent trimmer to form 3’end . Following methylation in cytoplasm, the mature piRNA-piwi complex is producted. Abbreviations: TSS: transcription start site; Zuc: zucchini Two major pathways generate piRNAs piRNA clusters produce primary piRNAs that are transported to the cytoplasmic Yb body [24, 25]. Zucchini (Zuc) and its co-factor Minotaur (Mino) incise primary piRNAs, producing piRNA intermediates with a 5′ uracil [26, 27]. Piwi protein contains an evolutionarily conserved structure consisting of a PAZ and piwi domain. PAZ preferentially binds piRNA intermediates with 5′ uracil, as observed for silkworm piwi in vitro [28]. Upon binding to piwi protein, piRNAs mature through 3′-end cleavage by the Zuc riboendonuclease [29], or via the Papi-dependent trimmer. Subsequent methylation by Hen1 yields the mature piRNA-piwi complex [3, 30] (Fig. 1). piRNA/piwi protein function and mechanism in cancer Recent studies indicate that piRNAs play a vital role in physiological and pathological processes at the transcriptional or post-transcriptional level. Here, we summarize the function and mechanisms of piRNAs in cancer (Fig. 2).Fig. 2piRNA/piwi protein function. a. At TGS level, the piRNA-proteins complex recruit silencing machinery components to bring repressive H3K9me3 marks to target DNA body and remove active H3K4me2 marks from promoter regions. In addition, piRNAs/piwi complex recruits DNMT, results in methylation at CpG sites in genic. b. At PTGS level, the piRNAs/piwi complex bind to targeted RNAs and impede their function by sequence complementary. c. piRNAs/piwi complex-protein interaction. The interaction between piRNAs/piwi and proteins alter the subcellular localization of proteins and facilitate the interaction of multiple proteins. Abbreviations: TGS: transcription gene silencing; PTGS: post-transcription gene silencing; H3K9me3: histone 3 lysine 9 trimethylation; H3K4me2: histone 3 lysine 4 dimethylation; DNMT: DNA methyltransferase piRNAs/piwi complex-mediated transcriptional gene silencing (TGS) piRNA/piwi complexes enter the nucleus and bind its genomic target through a nascent transcript by sequence complementary. Once combined with Panoramix (Panx), the piRNA-proteins complex induces TGS by recruiting silencing machinery components. Eggless (Egg) and its co-factor Windei (Wde) add repressive histone 3 lysine 9 trimethylation (H3K9me3) marks to the target DNA; subsequently, heterochromatin protein 1 (HP1) is recruited, causing heterochromatin formation. Lysine-specificdemethylase1 (Lsd1) removes activating H3K4me2 marks from promoter regions, inhibiting RNA Pol II transcription [31]. piRNA/piwi complex also recruits DNA methyltransferase (DNMT) to methylate genic CpG sites (non-transposable element (TE) protein-coding), altering transcriptional activity [32](Fig. 2a). In Aplysia neurons, an endogenously expressed piRNA induced CREB2 promoter methylation [33]. Furthermore, expression of a “piRNA-like” 28-nt transcript antisense to the KIR3DL1 promoter strongly correlated with KIR3DL1 promoter methylation in CD56+ natural killer cells [34]. piR-021285 overexpression facilitated ARHGAP11A methylation at a CpG site within the 5′UTR/first exon, decreasing mRNA (pro-apoptosis) expression and inhibiting BC cell apoptosis [35]. In multiple myeloma (MM), piRNA-823 directly recruited de novo DNA methyltransferases DNMT3A and DNMT3B in primary CD138+ MM cells, increasing global DNA methylation and inhibiting tumor suppressor p16INK4A expression [36]. piRNAs/piwi complex- mediated post-transcriptional gene silencing (PTGS) Numerous studies have found that many piRNAs regulate post-transcriptional networks to inhibit target function through piRNA-RNA interactions, similar to miRNA mechanisms. These RNAs include mRNA [37], transcribed pseudogenes [22], and long noncoding RNA (lncRNA) [38]. Effective mRNA: piRNA interaction requires strict base pairing within 2–11 nt at the 5′-end of piRNA and less stringent base pairing within 12–21 nt [39] (Fig. 2b). Functional piRNA-induced silencing complexes (pi-RISCs), comprised of MIWI, piRNAs, and CAF1 deadenylase in mouse elongating spermatids, mediate mRNA deadenylation and decay via an miRNA-like mechanism with guider piRNAs